尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Peters Richard, Président et CEO. Director active across 3 companies, notably Aprea Therapeutics, Inc.. Aggregated, 15 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €55k. History available since 30 June 2021. The latest transaction was disclosed on 23 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 条申报中的 15 条
Peters Richard is Président et CEO. He has 15 filings, and across the 15 filings recorded, the sampled recent transactions span 2021-07-01 to 2026-06-17, with EUR 0 of buys and EUR 55084 of sells. His listed companies are Aprea Therapeutics, Inc., where he is Director, Yumanity Therapeutics, INC., where he is President and CEO, and Kineta, Inc./de, where he is Director.